▲ Up
 
14:14 29-05-2015
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
13:36 Korea Eximbank to provide US$3bn loans to Uzbekistan13:20 Surgeons of Bishkek, Berlin to jointly operate patients with burn injuries for free13:11 Young Australian women trying to join IS, say police13:03 Turkmenistan might extend presidential term up to seven years12:44 PMs of Kyrgyzstan and Russia discuss Kambar-Ata HPP and upper-Naryn cascade construction12:26 CIS Council of Heads of Government adopt action plan on financial sphere12:19 Kyrgyzstan intends to resolve issue of Kyrgyz-Tajik border delimitation12:17 Volcano erupts on southern Japanese island11:50 Kyrgyzstani wins bronze medal at International Mendeleev Chemistry Olympiad11:43 42 minors commit suicide in Q1 201411:39 Head of Bishkek Humanities University department detained for receiving bribe11:35 54 minors have experienced sexual offenses in Q1 201511:29 More than 300 thousand families need housing in Kyrgyzstan, MP says11:23 Majority coalition to consider distribution of $100 million received for Jerooy competition11:23 Kazakhstan's national holding KazAgro changes chairman11:17 Head of Department of Tourism Maksat Chakiyev detained for bribery on large scale11:11 Tajikistan recognizes Jabhat al-Nusra and Islamic State terrorist organizations10:57 Chairman of committee on education discusses vocational and technical education with German colleagues10:55 Kazakhstan hosts meetings of CIS Council of Heads of Government and Eurasian Intergovernmental Council on Friday10:51 Osh interregional hospital to receive equipment from India to establish telemedicine center
Astana
+22° C
Ashgabat
+35° C
Bishkek
+29° C
Dushanbe
+28° C
Tashkent
+32° C
exchange rates
 
63.62
58.15
9.43
1.11
203.17
185.80
29.97
3.56
6.86
6.27
1.01
0.13
2710.18
2512.73
405.44
50.01
3.83
3.50
0.56
0.07

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75